MAGLIE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.004
AS - Asia 3.514
EU - Europa 3.126
SA - Sud America 452
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 71
OC - Oceania 46
Totale 12.322
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.887
RU - Federazione Russa 1.290
CN - Cina 1.117
SG - Singapore 973
IT - Italia 714
HK - Hong Kong 391
BR - Brasile 377
KR - Corea 349
IE - Irlanda 288
VN - Vietnam 262
DE - Germania 176
SE - Svezia 143
IN - India 127
FI - Finlandia 120
PL - Polonia 108
FR - Francia 107
BD - Bangladesh 79
CA - Canada 75
GB - Regno Unito 67
JO - Giordania 50
AU - Australia 45
ID - Indonesia 38
JP - Giappone 34
AR - Argentina 26
NL - Olanda 22
NG - Nigeria 20
MX - Messico 19
EC - Ecuador 18
UA - Ucraina 15
ES - Italia 14
IQ - Iraq 12
BJ - Benin 10
CH - Svizzera 10
PH - Filippine 10
PK - Pakistan 10
LT - Lituania 9
MK - Macedonia 9
AE - Emirati Arabi Uniti 8
AT - Austria 8
CI - Costa d'Avorio 8
ZA - Sudafrica 8
CO - Colombia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
MA - Marocco 6
TR - Turchia 6
VE - Venezuela 6
IL - Israele 5
PY - Paraguay 5
TN - Tunisia 5
AZ - Azerbaigian 4
NO - Norvegia 4
NP - Nepal 4
PE - Perù 4
BG - Bulgaria 3
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
JM - Giamaica 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
BE - Belgio 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
KE - Kenya 2
KZ - Kazakistan 2
ML - Mali 2
PA - Panama 2
RO - Romania 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LI - Liechtenstein 1
MM - Myanmar 1
MT - Malta 1
Totale 12.203
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.521
Singapore 714
Ashburn 494
Hefei 416
Seoul 346
Hong Kong 330
Dublin 284
Fairfield 222
Council Bluffs 168
Chandler 154
Milan 150
San Jose 142
Beijing 123
Moscow 111
Munich 104
Warsaw 103
Los Angeles 102
Buffalo 101
Houston 92
Seattle 91
Helsinki 90
Florence 84
Woodbridge 83
Ho Chi Minh City 78
Cambridge 77
Kent 72
Lauterbourg 64
Chicago 63
Lawrence 63
Mumbai 63
Wilmington 62
Rome 61
Altamura 57
The Dalles 57
Hanoi 55
Melbourne 43
New York 42
Dallas 41
Princeton 35
Boston 34
Jakarta 31
São Paulo 29
Ann Arbor 27
Paris 26
Shanghai 26
Frankfurt am Main 25
Tokyo 24
Bremen 21
Bengaluru 20
Boardman 20
Clifton 20
Medford 20
Pune 20
Abuja 19
Salt Lake City 19
Elk Grove Village 18
Rio de Janeiro 18
San Diego 18
West Jordan 18
Orem 15
Toronto 15
Da Nang 14
Guangzhou 14
Lappeenranta 14
Montreal 13
London 12
Naples 12
Norwalk 12
Secaucus 12
Bologna 11
Phoenix 11
Turin 11
Brasília 10
Cardiff 10
Cotonou 10
Dong Ket 10
Palermo 10
Tampa 10
Denver 9
Figino 9
Haiphong 9
Shenzhen 9
Abidjan 8
Atlanta 8
Guarulhos 8
Miano 8
Turku 8
Waltham 8
Brooklyn 7
Hillsboro 7
Hải Dương 7
Manchester 7
Miami 7
Redondo Beach 7
Tianjin 7
Belo Horizonte 6
Bern 6
Chennai 6
Figline Valdarno 6
Gorlago 6
Totale 7.800
Salva come PNG Salva come JPEG
Nome #
Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoid 316
miRNA-203b-3p induces acute and chronic pruritus via 5-HTR2B and TRPV4 307
Dermatitis Herpetiformis: Novel Perspectives 277
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 257
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center 220
Squamous cell carcinoma developed after ingenol mebutate therapy: a possible consequence of the treatment? 218
B-cell targeted therapies in pemphigus 213
Granular Deposits of IgA in the Skin of Coeliac Patients Without Dermatitis Herpetiformis: A Prospective Multicentric Analysis 208
Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge 200
Fatal occurrence of acquired haemophilia A in a patient with pemphigus vulgaris 197
Clinical Patterns, Survival, Comorbidities, and Treatment Regimens in 149 Patients With Pemphigus in Tuscany (Italy): A 12-Year Hospital-Based Study 195
Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease 190
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 185
Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study 182
Localized pemphigus exacerbation associated with underlying breast cancer 180
Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association? 177
T-Cell Response in Dermatitis Herpetiformis: May Epidermal Transglutaminase Play a Role in Predicting Clinical Relapse? 168
Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab 168
Alterations of circulating free fatty acids in patients with pemphigus vulgaris 167
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV) 164
Cutaneous eruptions associated with haematologic malignancies: the need for a unifying nomenclature 163
Indirect immunofluorescence in mucous membrane pemphigoid: which substrate should be used? 161
Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy 161
Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment 160
Dupilumab for the treatment of recalcitrant eosinophilic dermatosis of haematologic malignancy 160
A case of blood sweating: hematohidrosis syndrome 159
Lepromatous leprosy presenting with erythema nodosum leprosum mimicking Bechet's disease 159
Response to "Hematologic-Related Malignancy-Induced Eosinophilic Dermatosis (He Remained): An Eosinophilic Dermatosis Predominantly Associated with Chronic Lymphocytic Leukemia". 159
Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience 158
Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab 158
Rapid and sustained response to tralokinumab in a patient with severe bullous pemphigoid and end-stage kidney disease 155
Tralokinumab efficacy in a case of dupilumab-resistant severe atopic dermatitis complicated by eczema herpeticum 155
At the Root: Cutaneous Langerhans Cell Histiocytosis. 155
Is chemotherapy the best option for chronic lymphocytic leukemia associated Wells’ syndrome? Reply to “Case of Wells’ syndrome: A rare association with the clinical course of chronic lymphocytic leukemia” 152
Post-Surgical Anti-BP230 Bullous Pemphigoid: A Rare Cause of Non-Healing Wound 151
Impressive response of erosive pustular dermatosis of the scalp to lymecycline monotherapy 151
Marie Antoinette syndrome following COVID-19 vaccination 149
Specific dermatoses of pregnancy other than pemphigoid gestationis 149
A giant annular rash in a woodman: the many faces of erythema chronicum migrans 147
Inverted-U serration pattern: a novel clue for the diagnosis of anti-laminin-γ1 pemphigoid 146
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets 143
Myelodysplasia cutis as the presenting sign of chronic myelomonocytic leukaemia 142
T helper type 1-related molecules as well as interleukin-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum 141
Corrigendum: S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV) 140
Human Desmocollin 3‒Specific IgG Antibodies Are Pathogenic in a Humanized HLA Class II Transgenic Mouse Model of Pemphigus 140
Folliculitis decalvans with exclusive beard involvement 139
Sweet syndrome following sars-cov2 vaccination 139
Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry 137
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?” 136
Comment on "Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis". 135
Cutaneous leukocytoclastic vasculitis in B-cell chronic lymphocytic leukaemia patients. 133
Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy 133
The role of trpa1 in skin physiology and pathology 131
Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome-From Pemphigus to Lichenoid Dermatitis 131
Unilateral generalised morphea successfully treated with rituximab and mycophenolate mofetil 124
The skin doesn't lie: a case of dermatitis herpetiformis in the setting of refractory coeliac disease 124
Serration pattern analysis as a tool for the diagnosis of immunoglobulin A-mediated epidermolysis bullosa acquisita 123
Mucous membrane pemphigoid with lichen planus-like features: not only in the oral mucosa 123
Reply to "Comment on "Fatal occurrence of acquired haemophilia A in a patient with pemphigus vulgaris" 121
Propranolol Off-Target: A New Therapeutic Option in Neutrophil-Dependent Dermatoses? 120
Pemphigus: Current and Future Therapeutic Strategies 118
Assessment of serious infections in pemphigus and pemphigoid by a national registry 114
Is it really possible to cure hairy cell leukemia patients only with frontline therapy? 113
Reply to ‘Pruritic arthropod bite-like papules in T-cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia’ 113
Visual Dermatology: Self-Induced Chronic Saxophone Penis Due to Paraffin Injections 108
Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma 108
Improving the diagnosis of autoimmune blistering dermatoses of the oral mucosa 106
Targeted Therapies for Autoimmune Bullous Diseases: Current Status 105
Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma 100
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients 98
Reply to 'Comments on the first European guideline for paraneoplastic autoimmune multiorgan syndrome' 93
Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine 92
Pharmacological advances in pemphigoid 91
Pathogenetische Bedeutung von Antikörpern gegen Desmoglein 3 bei Patienten mit oralem Lichen planus 88
Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus 87
Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma 87
The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients 87
Nivolumab-induced erosive pustular dermatosis of the scalp 84
It is time to reconsider antibodies against integrin β4 in mucous membrane pemphigoid: Comment on 'Native collagen XVII complex ELISA: An approach for diagnosis and monitoring of anti-integrin β4 mucous membrane pemphigoid' 77
Role of autologous stem cell transplantation in T-cell lymphoma patients: a single institution retrospective analysis 76
High-throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid 67
A 14-year multicentric follow-up study of atypical pemphigus variants in Italy: the VARIANT_P study 51
Oral Erosive Lichen Planus Successfully Treated with Baricitinib 48
Baricitinib improved morphoea manifestations in a patient with alopecia areata universalis 40
BP230-Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center 39
A Specific Signature of Circulating Free Fatty Acid Discriminates Bullous Pemphigoid From Pemphigus Vulgaris and Healthy Controls 38
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study 26
The role of serological investigations in the diagnosis of bullous pemphigoid: a retrospective study 24
Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigus 24
Off-label use of tralokinumab in the treatment of bullous pemphigoid: a case series 21
Management of Bullous Pemphigoid in Special Populations: A Narrative Review of the Literature 17
Hand Edema and waxy papular eruption: a dermatologic riddle 16
Peptide Epitopes of NC16A BP180 in the Diagnostics of Bullous Pemphigoid 14
Totale 12.322
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.306
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022294 0 40 40 16 3 22 7 27 14 14 36 75
2022/2023989 62 167 65 74 42 172 160 67 116 20 26 18
2023/2024697 27 44 93 39 43 108 29 137 25 73 58 21
2024/20254.308 134 386 202 509 1.121 723 123 178 227 269 178 258
2025/20264.877 453 743 735 496 405 111 432 188 287 312 175 540
2026/2027345 225 120 0 0 0 0 0 0 0 0 0 0
Totale 12.322